Literature DB >> 28078118

Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer?

Jaiprakash Gurawalia1, Kapil Dev1, Sandeep P Nayak1, Vishnu Kurpad1, Arun Pandey1.   

Abstract

BACKGROUND: The number of lymph node retrieved in the surgical specimen is important for tumor staging and has paramount impact on prognosis in colorectal cancer and imitates the adequacy of lymph node surgical clearance. The paucity of lymph node yields in patients undergoing resection after preoperative chemo radiotherapy (CRT) in rectal cancer has seen. Lower total number of lymph nodes in the total mesoractal excision (TME) specimen after CRT, could a marker of better tumor response.
METHODS: We retrospectively reviewed the prospectively managed data of patients underwent excision for rectal cancer, who treated by neoadjuvant radiotherapy with or without chemotherapy in locally advanced rectal cancer. From 2010 to 2014, 364 patients underwent rectal cancer surgery, of which ninety-one treated with neoadjuvant treatment. Standard surgical and pathological protocols were followed. Patients were categorized into two groups based on the number of total harvested lymph nodes with group 1, having 12 or more nodes harvested, and group 2 including patients who had <12 lymph nodes harvested. The total number of lymph nodes retrieved from the surgical specimen was correlated with grade of tumor regression with neoadjuvant treatment.
RESULTS: Out of 91 patients, 38 patients (42%) had less than 12 lymph nodes examined in specimen. The difference in median number of lymph nodes was observed significantly as 9 (range, 2-11) versus 16 (range, 12-32), in group 2 and 1, respectively (P<0.01). Patients with fewer lymph node group were comparable with respect to age, BMI, pre-operative staging, neoadjuvant treatment. Pathological complete response in tumor pCR was seen with significantly higher rate (40% vs. 26%, P<0.05) in group 2. As per Mandard criteria, there was significant difference in tumor regression grade (TRG) between both the groups (P<0.05). Among patients with metastatic lymph nodes, median LNR was lower in <12 lymph nodes group at 0.167 (range, 0.09-0.45) versus 0.187 (range, 0.05-0.54), difference was not statistically significant (P=0.81).
CONCLUSIONS: Retrieval of fewer than 12 lymph nodes in surgical specimen of rectal cancer who had received neo-adjuvant radiotherapy with or without chemotherapy should be considered as a good indicator of tumor response with better local disease control, and a good prognostic factor, rather than as a pointer of poor diligence of the surgical and pathological assessment.

Entities:  

Keywords:  Rectal carcinoma; lymph node yield; mesorectal excision; pre-operative chemo-radiotherapy; tumor regression

Year:  2016        PMID: 28078118      PMCID: PMC5177569          DOI: 10.21037/jgo.2016.09.03

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  46 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance.

Authors:  Dietrich Doll; Ralf Gertler; Matthias Maak; Jan Friederichs; Karen Becker; Hans Geinitz; Monika Kriner; Hjalmar Nekarda; Jörg R Siewert; Robert Rosenberg
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

3.  Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

Authors:  L P Fielding; P A Arsenault; P H Chapuis; O Dent; B Gathright; J D Hardcastle; P Hermanek; J R Jass; R C Newland
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

4.  The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

Authors:  Robert Rosenberg; Jutta Engel; Christiane Bruns; Wolfgang Heitland; Nikolaus Hermes; Karl-Walter Jauch; Reinhard Kopp; Eberhard Pütterich; Reinhard Ruppert; Tibor Schuster; Helmut Friess; Dieter Hölzel
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

5.  The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.

Authors:  M Beresford; R Glynne-Jones; P Richman; A Makris; S Mawdsley; D Stott; M Harrison; M Osborne; R Ashford; J Grainger; J Al-Jabbour; I Talbot; I C Mitchell; J Meyrick Thomas; J I Livingstone; J McCue; P MacDonald; J A M Northover; A Windsor; R Novell; M Wallace; R A Harrison
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

6.  Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis.

Authors:  Nancy N Baxter; Arden M Morris; David A Rothenberger; Joel E Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

7.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

8.  For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Authors:  S Caplin; J P Cerottini; F T Bosman; M T Constanda; J C Givel
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

9.  Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Viviane Rawet; Diego D Pereira; Afonso H S Sousa; Desiderio Kiss; Ivan Cecconello
Journal:  Dis Colon Rectum       Date:  2008-03       Impact factor: 4.585

10.  Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer.

Authors:  Woo Ram Kim; Yoon Dae Han; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more
  7 in total

1.  Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma.

Authors:  Guillaume Chotard; Maylis Capdepont; Quentin Denost; Denis Smith; Véronique Vendrely; Eric Rullier; Anne Rullier
Journal:  Virchows Arch       Date:  2021-05-13       Impact factor: 4.064

2.  Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer.

Authors:  Sumana Narayanan; Kristopher Attwood; Emmanuel Gabriel; Steven Nurkin
Journal:  J Surg Res       Date:  2020-03-12       Impact factor: 2.192

3.  Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance.

Authors:  Dedrick Kok Hong Chan; Ker-Kan Tan
Journal:  J Gastrointest Oncol       Date:  2019-02

4.  Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Tianlei Xu; Lin Zhang; Liang Yu; Yuelu Zhu; Hui Fang; Bo Chen; Haizeng Zhang
Journal:  Ann Transl Med       Date:  2021-04

5.  Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.

Authors:  Takashi Okuyama; Shinichi Sameshima; Emiko Takeshita; Ryuji Yoshioka; Yukinori Yamagata; Yuko Ono; Nobumi Tagaya; Tamaki Noie; Masatoshi Oya
Journal:  World J Surg Oncol       Date:  2018-06-05       Impact factor: 2.754

6.  Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Yaqi Wang; Menglong Zhou; Jianing Yang; Xiaoyang Sun; Wei Zou; Zhiyuan Zhang; Jing Zhang; Lijun Shen; Lifeng Yang; Zhen Zhang
Journal:  Cancer Med       Date:  2019-06-28       Impact factor: 4.452

7.  The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy.

Authors:  Zhuangbin Lin; Xiaobo Li; Jianyuan Song; Rong Zheng; Cheng Chen; Anchuan Li; Benhua Xu
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.